Cristin-resultat-ID: 1321430
Sist endret: 20. februar 2016, 11:57
NVI-rapporteringsår: 2015
Resultat
Vitenskapelig artikkel
2015

Effect of systematic follow-up by general practitioners after deliberate self-poisoning: A randomised controlled trial

Bidragsytere:
  • Tine Kristin Grimholt
  • Dag Jacobsen
  • Ole Rikard Haavet
  • Leiv Sandvik
  • Trond Jørgensen
  • Astrid Berge Norheim
  • mfl.

Tidsskrift

PLOS ONE
ISSN 1932-6203
e-ISSN 1932-6203
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2015
Volum: 10:e0143934
Hefte: 12
Open Access

Importkilder

Scopus-ID: 2-s2.0-84955449146

Beskrivelse Beskrivelse

Tittel

Effect of systematic follow-up by general practitioners after deliberate self-poisoning: A randomised controlled trial

Sammendrag

Objective To assess whether systematic follow-up by general practitioners (GPs) of cases of deliberate self-poisoning (DSP) by their patients decreases psychiatric symptoms and suicidal behaviour compared with current practice. Design Randomised clinical trial with two parallel groups. Setting General practices in Oslo and the eastern part of Akershus County. Participants Patients aged 18–75 years admitted to hospital for DSP.We excluded patients diagnosed with psychoses, without a known GP, those not able to complete a questionnaire, and patients admitted to psychiatric in-patient care or other institutions where their GP could not follow them immediately after discharge. Intervention The GPs received a written guideline, contacted the patients and scheduled a consultation within one week after discharge, and then provided regular consultations for six months. We randomised the patients to either intervention (n = 78) or treatment as usual (n = 98). Main Outcome Measures Primary outcome measure was the Beck Scale for Suicide Ideation (SSI). Secondary outcomes were Beck Depression Inventory (BDI) and Beck Hopelessness Scale (BHS), selfreported further self-harm and treatment for DSP in a general hospital or an emergency medical agency (EMA). We assessed patients on entry to the trial and at three and six months. We collected data from interviews, self-report questionnaires, and hospital and EMA medical records. Results There were no significant differences between the groups in SSI, BDI, or BHS mean scores or change from baseline to three or six months. During follow-up, self-reported DSP was 39.5% in the intervention group vs. 15.8% in controls (P = 0.009). Readmissions to general hospitals were similar (13% in both groups (P = 0.963), while DSP episodes treated at EMAs were 17% in the intervention group and 7% in the control group (P = 0.103). Conclusion Structured follow-up by GPs after an episode of DSP had no significant effect on suicide ideation, depression or hopelessness. There was no significant difference in repeated episodes of DSP in hospitals or EMAs. However, the total number of incidents of deliberate self-harm reported by the patients was significantly higher in the intervention group. Trial registration Trial registration ClinicalTrials.gov Identifier: NCT01342809

Bidragsytere

Tine Kristin Grimholt

  • Tilknyttet:
    Forfatter
    ved Regionale ressurssentre om vold, traumatisk stress og selvmordsforebygging
  • Tilknyttet:
    Forfatter
    ved Akuttmedisinsk avdeling ved Oslo universitetssykehus HF

Dag Jacobsen

  • Tilknyttet:
    Forfatter
    ved Akuttmedisinsk avdeling ved Oslo universitetssykehus HF
Inaktiv cristin-person

Ole Rikard Haavet

  • Tilknyttet:
    Forfatter
    ved Avdeling for allmennmedisin ved Universitetet i Oslo
Aktiv cristin-person

Leiv Sandvik

  • Tilknyttet:
    Forfatter
    ved Biostatistikk, epidemiologi og helseøkonomi (OSS) ved Oslo universitetssykehus HF

Trond Jørgensen

  • Tilknyttet:
    Forfatter
    ved Divisjon for psykisk helsevern ved Akershus universitetssykehus HF
1 - 5 av 7 | Neste | Siste »